/ Print /

IN THE PIPELINE

Fighting against glaucoma-therapy related ocular surface diseaseOcular surface disease (OSD) and dry eye disease (DED) are very common problems in the elderly, and they both considerably decrease vision-related quality of life.
FDA warns about opioid-containing supplementFDA said the manufacturer of dietary supplements containing kratom, a natural opioid used to treat opioid use disorder, agreed to destroy the supplements, and is again warning the public about kratom.
New warning on antibiotic for heart disease patients
New warning on antibiotic for heart disease patientsFDA is advising caution before healthcare professionals prescribe a certain antibiotic to patients with heart disease due to a potential increased risk of heart problems or death that can occur years later.
Painting a picture of brain-related vision problemsBritish installation artist, Luke Jerram, and researchers at Bristol Vision Institute, are creating something that will raise awareness about the nature of cerebral visual impairment in an artist’s residency at the University of Bristol in the United Kingdom.
3 new FDA drug approvalsFDA recently approved 3 major drugs to treat lung cancer, prostate cancer, and cystic fibrosis. Here are the top 3 new drug approvals.
Patient group pushes FDA to improve biosimilar educationFDA should provide better education about biosimilar drugs on the agency’s web site dedicated to biosimilars, a patient advocacy group said.
Device restores vision to patient with Stargardt diseaseAn artificial vision device (MyEye, OrCam) has helped a blind veteran regain his independence, according to the charity Scottish War Blinded.
Trying new things in medicineMy classmate in medical school, Eric, only became a medical student because his father insisted. Eric wasn’t happy about this until he discovered he loved ophthalmology. He went on to perform brilliantly as a resident and built an extremely successful and fulfilling practice. Eric’s story is not unique.
MACRA changes are part of volume-to-value shiftThe Medicare Access and CHIP Reauthorization Act of 2015 and its Merit Based Incentive Payments System are here to stay for the foreseeable future and are likely to significantly impact reimbursement for ophthalmologists as part of a shift away from traditional fee for service medicine. In this changing landscape, eye care practitioners need to understand the basics of the system, such as reporting requirements, and begin to consider new models of care.
Opioid prescription limits gain support
Opioid prescription limits gain supportA pharmacist organization is among the supporters of a new Medicare Part D proposal, which calls for a 7-day supply limit on opioid prescriptions.